Human vaccine development company BigDNA has added two animal health experts to its Scientific Advisory Panel as it cements its expansion into the animal health sector.
BigDNA is welcoming Dr Colin Giles, a consultant on product development in the sector, and veterinary consultant Dr Tim Rowan, to its panel of scientific advisers.
Making the announcement, Dr John March, BigDNA's chief executive, said: "Colin Giles and Tim Rowan bring an important range of expertise to our scientific panel, which will help us develop our vaccine technology in the animal health arena, alongside expanding our core human vaccine programme. They join a distinguished group of scientific and business advisers, all world experts in their fields, who will help us to formulate our scientific strategy and drive forward our new technology and business."
Dr Colin Giles is a former Vice President of R&D for Pfizer Animal Health where he oversaw the development and regulatory approval of new chemical entities for veterinary medicine - many of which are now well-established veterinary products.
Dr Tim Rowan held a number of senior positions in Pfizer Animal Health R & D, in the clinical development and discovery sectors. Several of the new veterinary products he worked on now generate sales in excess of $100million per annum.
BigDNA - winner of last year's Scottish Enterprise ‘Best New Life Sciences Company in Scotland'- is developing a new vaccine technology that is based upon using bacteriophage to deliver a DNA vaccine. This technology will allow for rapid, cost effective manufacturing of vaccines, which are stable for ease of storage and transport. Products under development include human vaccines against Hepatitis B, Influenza and Chlamydia.
Other members of the BigDNA's Scientific Advisory panel are: distinguished molecular geneticist Professor Noreen Murray; Dr John Beadle, formerly founder and Chief Medical Officer at PowerMed (sold to Pfizer); Dr Dan McLain, formerly Director of Toxicology at Powderject Vaccines; Max Gottesman, Professor of Biochemistry and Molecular Biophysics and Microbiology at Columbia University; Dr Steve Abedon, Associate Professor at the Department of Microbiology, Ohio State University and Dr Arvind Mahajan, a cellular microbiologist leading vaccine research on food borne pathogens at the University of Edinburgh.